PACS and RIS Market to Grow at a CAGR of 8.4% to reach US$ 5,441.87 Million from 2020 to 2027

PACS and RIS Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (PACS and RIS), Component (Hardware, Software, and Services), Deployment (Web-Based, On-Premise and Cloud-Based), End User (Hospitals, Diagnostic Centers, Research & Academic Institutes, and Other End Users), and Geography.

  • Report Code : TIPRE00003005
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 203
Buy Now

[Research Report] The PACS and RIS Market was valued at US$ million 2,836.65 in 2019 and is projected to reach US$ 5,441.87 million by 2027; it is expected to grow at a CAGR of 8.4% from 2020 to 2027.

The picture archiving and communication system (PACS) manages, retrieves, stores, and distributes the medical images. In the field of radiology, it is used for sharing and viewing diagnostic images. A radiology information system (RIS) is a software system used for handling medical images and other associated data. RIS retains track of radiology imaging orders and data of bills. It is used along with PACS and vendor-neutral archives (VNAs). RIS manages image archives, keeps records, and billing.  

The PACS and RIS market is segmented based on component, deployment, end user, and region. The market for PACS and RIS is analyzed based on regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the PACS and RIS market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world.  

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

PACS and RIS Market: Strategic Insights

pacs-and-ris-market
Market Size Value inUS$ 2,836.65 million in 2019
Market Size Value byUS$ 5,441.87 Million by 2027
Growth rateCAGR of 8.4% from 2020 to 2027
Forecast Period2020 - 2027
Base Year2020
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst


Lucrative Regions for PACS and RIS Market

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Market Insights


Developments in Diagnostic Imaging Modalities Coupled with Rising Number of Diagnostic Tests Procedures

During recent years, there have been various developments in imaging modalities within healthcare for diagnostic purposes. Radiology has developed as a recent trend toward computerized management in the health service and has responded to the demand for cost-efficient and rapid communication between radiology departments and their users. The national rate for CT scans were 126 per 1,000 individuals in between 2014 and 2015. Rates ranged from 209 (New Brunswick) and 170 (Newfoundland and Labrador) to 88 (Alberta) and 93 (Prince Edward Island). According to the National Health Services (NHS) UK, there were 4.1 million imaging tests conducted in England in the 12 months from February 2017 to January 2017. Of these, 3.49 million imaging tests were reported to have taken place in January 2017. As per the World Health Organization (WHO), with improved health care policy and the guided protocol of medical imaging for COVID-19 diagnosis, there has been a rise in the number of global imaging-based procedures. Thus, the growing number of diagnostic imaging procedures performed across the world resulting in the increasing requirement of consumables for tests are expected to drive the growth of the global PACS and RIS market in the coming years.

PACS and RIS Products -Based Insights              

Based on products, the PACS and RIS market is segmented into picture archiving and communication system (PACS) and radiology information system (RIS). The PACS segment is further segmented into orthopedic PACS, oncology PACS, cardiology PACS, dental PACS, and others. In 2019, the PACS segment accounted for a larger share of the market, and is expected to register a higher CAGR in the PACS and RIS market during the forecast period. Growth of this segment is attributed to increasing adoption of PACS systems in radiological procedures. Further, the orthopedic sub-segment held a major market share.

Global PACS and RIS Market, by Component – 2019 & 2027

Global PACS and RIS Market, by Component – 2019 & 2027
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Deployment-Based Insights

Based on deployment, the PACS and RIS market is segmented into Web-Based, On-Premise and Cloud-Based. The web-based segment held the largest share of the market in 2019; whereas, the cloud-based segment is anticipated to register the highest CAGR of 9.5% in the market during the forecast period.   

End User – Based Insights

Based on end user, the PACS and RIS market is segmented into hospitals, diagnostic centers, research & academic institutes, and other end users. The hospitals segment held the largest share of the market in 2019, and is anticipated to register the highest CAGR of 8.9% in the market during the forecast period.

COVID-19 pandemic has become the most significant challenge across the world. The demand for PACS and RIS have increased in hospitals as the fast and easily accessible patient imaging is crucial in the treatment of COVID-19 patient. In April, the US Food and Drug Administration (FDA) has approved Intelerad’s InteleConnect EV solution for diagnostic imaging review on a range of mobile devices. This approval comes at a critical time for healthcare systems and ensures that radiologists are able to collaborate and leverage resources in creative ways, even when workstation access is not available. It also is approved for mobile diagnostic image review, and can immediately be used on various iPad and iPhone models, with additional devices on the horizon. All these factors are expected to bring positive prospects for the growth of the PACS and RIS market during this pandemic crisis.   

Product launches and expansion strategy are commonly adopted by companies to expand their footprint worldwide and meet the growing demand. These strategies are commonly adopted by the market players in order to expand its product portfolio.

The market players operating in the

PACS and RIS Market

adopted the strategy of product innovation to cater the changing customer demand across the world, which also permits the players to maintain their brand name globally.

By Product

  • PACS
    • Orthopedic PACS
    • Cardiology PACS
    • Oncology PACS
    • Dental PACS
    • Others
  • RIS


By Component    

  • Software
  • Hardware
  • Services


By Deployment

  • Web Based
  • On Premise
  • Cloud Based


By End User

  • Hospitals
  • Diagnostic Centers
  • Others


By Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of the Europe
  • Asia Pacific(APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South America (SAM)

    • Brazil
    • Argentina
    • Rest of South America

Company Profiles

  • Agfa-Gevaert Group
  • INFINITT Healthcare Co., Ltd.
  • McKesson Corporation
  • Cerner Corporation
  • General Electric Company
  • Koninklijke Philips N.V.
  • FUJIFILM Holdings Corporation
  • Siemens AG
  • IBM
  • Novarad
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Type, Application, End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


Who are the major players in the PACS and RIS market?

The PACS and RIS market majorly consists of the players such as Agfa-Gevaert Group, INFINITT Healthcare Co., Ltd., McKesson Corporation, Cerner Corporation, General Electric Company, Koninklijke Philips N.V., FUJIFILM Holdings Corporation, Siemens AG, IBM, Novarad and among others.

What are the driving factors for the PACS and RIS market across the globe?

The factors that are driving growth of the market are developments in diagnostic imaging modalities coupled with rising number of diagnostic tests procedures, affordable price of new generation PACS software are expected to boost the growth of the global PACS and RIS market.

What is PACS and RIS?

The picture archiving and communication system (PACS) manages, retrieves, stores, and distributes the medical images. In the area of radiology, it is used for sharing and viewing diagnostic images. A radiology information system (RIS) is a software system used for handling medical images and other associated data. RIS retains track of radiology imaging orders and data of bills. It is used along with PACS and vendor-neutral archives (VNAs). RIS manages image archives, keeps records, and billing.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global PACS and RIS Market – By Product

1.3.2 Global PACS and RIS Market – By Component

1.3.3 Global PACS and RIS Market – By Deployment

1.3.4 Global PACS and RIS Market – By End User

1.3.5 Global PACS and RIS Market – By Geography

2. PACS and RIS Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global PACS and RIS Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East & Africa PEST Analysis

4.2.5 South & Central America PEST Analysis

4.3 Expert Opinions

5. Global PACS and RIS Market – Key Industry Dynamics

5.1 Key Market Drivers

5.1.1 Developments in Diagnostic Imaging Modalities Coupled with Rising Number of Diagnostic Tests Procedures

5.1.2 Affordable Price of New Generation PACS Software

5.2 Key Market Restraints

5.2.1 Availability of Better Substitutes

5.2.2 Concerns Regarding Data Privacy

5.3 Key Market Opportunities

5.3.1 Increasing Demand for Orthopaedic PACS

5.4 Key Market Trends

5.4.1 Technology Advancement and New Product Launches

5.5 Impact Analysis

6. PACS and RIS Market – Global Analysis

6.1 Global PACS and RIS Market Revenue Forecasts And Analysis

6.2 Global PACS and RIS Market, By Geography - Forecasts And Analysis

6.3 Positioning of Key Players

7. Global PACS and RIS Market Analysis– by Product

7.1 Overview

7.2 Global PACS and RIS Market, By Product, 2019 & 2027 (% Share)

7.3 Picture Archive and Communication System (PACS) Market

7.3.1 Overview

7.3.2 Global Picture Archive and Communication System (PACS) Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.3 Orthopedic PACS Market

7.3.3.1 Overview

7.3.3.2 Global Orthopedic PACS Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.4 Oncology PACS Market

7.3.4.1 Overview

7.3.4.2 Global Oncology PACS Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.5 Cardiology PACS Market

7.3.5.1 Overview

7.3.5.2 Global Cardiology PACS Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.6 Dental PACS Market

7.3.6.1 Overview

7.3.6.2 Global Dental PACS Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.7 Others Market

7.3.7.1 Overview

7.3.7.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

7.4 Radiology Information System (RIS) Market

7.4.1 Overview

7.4.2 Global Radiology Information System (RIS) Market Revenue and Forecasts to 2027 (US$ Mn)

8. Global PACS and RIS Market Analysis– by Component

8.1 Overview

8.2 Global PACS and RIS Market, By Component, 2019 & 2027 (% Share)

8.3 Software Market

8.3.1 Overview

8.3.2 Global Software Market Revenue and Forecasts to 2027 (US$ Mn)

8.4 Hardware Market

8.4.1 Overview

8.4.2 Global Hardware Market Revenue and Forecasts to 2027 (US$ Mn)

8.5 Services Market

8.5.1 Overview

8.5.2 Global Services Market Revenue and Forecasts to 2027 (US$ Mn)

9. Global PACS and RIS Market Analysis– by Deployment

9.1 Overview

9.2 Global PACS and RIS Market, By Deployment 2019 & 2027 (% Share)

9.3 Web-Based Market

9.3.1 Overview

9.3.2 Global Web-Based Market Revenue and Forecasts to 2027 (US$ Mn)

9.4 On-Premise Market

9.4.1 Overview

9.4.2 Global On-Premise Market Revenue and Forecasts to 2027 (US$ Mn)

9.5 Cloud-Based Market

9.5.1 Overview

9.5.2 Global Cloud-Based Market Revenue and Forecasts to 2027 (US$ Mn)

10. Global PACS and RIS Market Analysis– by End User

10.1 Overview

10.2 Global PACS and RIS Market, By End User, 2019 & 2027 (% Share)

10.3 Hospitals Market

10.3.1 Overview

10.3.2 Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

10.4 Diagnostic Centers Market

10.4.1 Overview

10.4.2 Global Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)

10.5 Others Market

10.5.1 Overview

10.5.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

11. PACS and RIS Market Revenue and Forecasts to 2027 – Geographical Analysis

11.1 North America PACS and RIS Market Revenue And Forecasts To 2027

11.1.1 North America PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.2 North America PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.1.3 North America PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.1.4 North America PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.1.5 North America PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.1.6 North America PACS and RIS Market Revenue and Forecasts to 2027, By Country (%)

11.1.7 US PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.7.1 US PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.7.2 US PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.1.7.3 US America PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.1.7.4 US PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.1.7.5 US PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.1.8 Canada PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.8.1 Canada PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.8.2 Canada PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.1.8.3 Canada PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.1.8.4 Canada PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.1.8.5 Canada PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.1.9 Mexico PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.9.1 Mexico PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.9.2 Mexico PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.1.9.3 Mexico PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.1.9.4 Mexico PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.1.9.5 Mexico PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2 Europe PACS and RIS Market Revenue And Forecasts To 2027

11.2.1 Europe PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.2 Europe PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.3 Europe PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.2.4 Europe PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.2.5 Europe PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.6 Europe PACS and RIS Market Revenue And Forecasts to 2027, By Country (%)

11.2.7 UK PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.7.1 UK PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.7.2 UK PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.7.3 UK PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.2.7.4 UK PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.2.7.5 UK PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.8 Germany PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.8.1 Germany PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.8.2 Germany PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.8.3 Germany PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.2.8.4 Germany PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.2.8.5 Germany PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.9 France PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.9.1 France PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.9.2 France PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.9.3 France PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.2.9.4 France PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.2.9.5 France PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.10 Italy PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.10.1 Italy PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.10.2 Italy PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.10.3 Italy PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.2.10.4 Italy PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.2.10.5 Italy PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.11 Spain PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.11.1 Spain PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.11.2 Spain PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.11.3 Spain PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.2.11.4 Spain PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.2.11.5 Spain PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.12 Rest of Europe: Medical Device Adhesive Market – Revenue and Forecast to 2027 (USD Million)

11.2.12.1 Rest of Europe PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.12.2 Rest of Europe PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.12.3 Rest of Europe PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.2.12.4 Rest of Europe PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.2.12.5 Rest of Europe PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.3 Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027

11.3.1 Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.2 Asia Pacific PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.3.3 Asia Pacific PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.3.4 Asia Pacific PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.3.5 Asia Pacific PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.3.6 Asia Pacific PACS and RIS Market Revenue And Forecasts to 2027, By Country (%)

11.3.7 Japan PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.7.1 Japan PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.7.2 Japan PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.3.7.3 Japan PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.3.7.4 Japan PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.3.7.5 Japan PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.3.8 China PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.8.1 China PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.8.2 China PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.3.8.3 China PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.3.8.4 China PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.3.8.5 China PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.3.9 India PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.9.1 India PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.9.2 India PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.3.9.3 India PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.3.9.4 India PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.3.9.5 India PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.3.10 South Korea PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.10.1 South Korea PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.10.2 South Korea PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.3.10.3 South Korea PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.3.10.4 South Korea PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.3.10.5 South Korea PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.3.11 Australia PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.11.1 Australia PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.11.2 Australia PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.3.11.3 Australia PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.3.11.4 Australia PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.3.11.5 Australia PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.3.12 Rest of Asia Pacific: PACS and RIS Market – Revenue and Forecast to 2027 (USD Million)

11.3.12.1 Rest of Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.12.2 Rest of Asia Pacific PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.3.12.3 Rest of Asia Pacific PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.3.12.4 Rest of Asia Pacific PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.3.12.5 Rest of Asia Pacific PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.4 Middle East & Africa PACS and RIS Market Revenue And Forecasts To 2027

11.4.1 Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.4.2 Middle East & Africa PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.4.3 Middle East & Africa PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.4.4 Middle East & Africa PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.4.5 Middle East & Africa PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.4.6 Middle East & Africa PACS and RIS Market Revenue And Forecasts to 2027, By Country (%)

11.4.7 UAE PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.4.7.1 UAE PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.4.7.2 UAE PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.4.7.3 UAE PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.4.7.4 UAE PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.4.7.5 UAE PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.4.8 Saudi Arabia PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.4.8.1 Saudi Arabia PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.4.8.2 Saudi Arabia PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.4.8.3 Saudi Arabia PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.4.8.4 Saudi Arabia PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.4.8.5 Saudi Arabia PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.4.9 South Africa PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.4.9.1 South Africa PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.4.9.2 South Africa PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.4.9.3 South Africa PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.4.9.4 South Africa PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.4.9.5 South Africa PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.4.10 Rest of Middle East and Africa: Medical Device Adhesive Market – Revenue and Forecast to 2027 (USD Million)

11.4.10.1 Rest of Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.4.10.2 Rest of Middle East & Africa PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.4.10.3 Rest of Middle East & Africa PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.4.10.4 Rest of Middle East & Africa PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.4.10.5 Rest of Middle East & Africa PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.5 South And Central America PACS and RIS Market Revenue And Forecasts To 2027

11.5.1 South and Central America PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.5.2 South and Central America PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.5.3 South and Central America PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.5.4 South and Central America PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.5.5 South and Central America PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.5.6 South and Central America PACS and RIS Market Revenue And Forecasts to 2027, By Country (%)

11.5.7 Argentina PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.5.7.1 Argentina PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.5.7.2 Argentina PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.5.7.3 Argentina PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.5.7.4 Argentina PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.5.7.5 Argentina PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.5.8 Brazil PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.5.8.1 Brazil PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.5.8.2 Brazil PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.5.8.3 Brazil PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.5.8.4 Brazil PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.5.8.5 Brazil PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.5.9 Rest of South and Central America: PACS and RIS Market – Revenue and Forecast to 2027 (USD Million)

11.5.9.1 Rest of South and Central America PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

11.5.9.2 Rest of South and Central America PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.5.9.3 Rest of South and Central America PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)

11.5.9.4 Rest of South and Central America PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)

11.5.9.5 Rest of South and Central America PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12. Impact of COVID-19 Pandemic on Global PACS and RIS Market

12.1 North America: Impact Assessment of COVID-19 Pandemic

12.2 Europe: Impact Assessment of COVID-19 Pandemic

12.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic

12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12.5 South and Central America: Impact Assessment of COVID-19 Pandemic

13. PACS and RIS Market– Industry Landscape

13.1 Overview

13.2 Growth Strategies In The PACS and RIS Market, 2017-2020

13.3 Inorganic Growth Strategies

13.3.1 Overview

13.4 Inorganic Growth Strategies in the PACS and RIS Market, 2017-2020 (%)

13.4.1 Collaborations

13.4.1.1 Recent Collaborations By Players In The PACS and RIS Market

13.4.2 Agreements, Partnerships and Joint Ventures

13.4.2.1 Recent Agreements, Partnerships And Joint Ventures By Players In The PACS and RIS Market

13.4.3 Acquisitions

13.4.3.1 Recent Acquisitions By Players In The PACS and RIS Market

13.5 Organic Growth Strategies

13.5.1 Overview

13.6 Organic Growth Strategies in the PACS and RIS Market, 2017-2020 (%)

13.6.1 Product Launches

13.6.1.1 Recent Product Launches By Players In The PACS and RIS Market

13.6.2 Product Approval & Other Organic Growth Strategies

13.6.2.1 Recent Product Approval & Other Organic Growth Strategies By Players In The PACS and RIS Market

14. PACS and RIS Market–Key Company Profiles

14.1 Agfa-Gevaert Group

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Financial Overview

14.1.4 Product Portfolio

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 INFINITT Healthcare Co., Ltd.

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Financial Overview

14.2.4 Product Portfolio

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 McKesson Corporation

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Financial Overview

14.3.4 Product Portfolio

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Cerner Corporation

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Financial Overview

14.4.4 Product Portfolio

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 General Electric Company

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Financial Overview

14.5.4 Product Portfolio

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Koninklijke Philips N.V.

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Financial Overview

14.6.4 Product Portfolio

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 FUJIFILM Holdings Corporation

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Financial Overview

14.7.4 Product Portfolio

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Siemens AG

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Financial Overview

14.8.4 Product Portfolio

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 IBM

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Financial Overview

14.9.4 Product Portfolio

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 Novarad

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Financial Overview

14.10.4 Product Portfolio

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary Of Terms

LIST OF TABLES

Table 1. North America PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 2. North America PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 3. North America PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 4. North America PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 5. US PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 6. US PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 7. US PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 8. US PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 9. Canada PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 10. Canada PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 11. Canada PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 12. Canada PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 13. Mexico PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 14. Mexico PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 15. Mexico PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 16. Mexico PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 17. Europe PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 18. Europe PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 19. Europe PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 20. Europe PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 21. UK PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 22. UK PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 23. UK PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 24. UK PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 25. Germany PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 26. Germany PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 27. Germany PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 28. Germany PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 29. France PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 30. France PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 31. France PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 32. France PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 33. Italy PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 34. Italy PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 35. Italy PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 36. Italy PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 37. Spain PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 38. Spain PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 39. Spain PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 40. Spain PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 41. Rest of Europe PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 42. Rest of Europe PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 43. Rest of Europe PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 44. Rest of Europe PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 45. Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 46. Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 47. Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 48. Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 49. Japan PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 50. Japan PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 51. Japan PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 52. Japan PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 53. China PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 54. China PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 55. China PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 56. China PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 57. India PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 58. India PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 59. India PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 60. India PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 61. South Korea PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 62. South Korea PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 63. South Korea PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 64. South Korea PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 65. Australia PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 66. Australia PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 67. Australia PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 68. Australia PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 69. Rest of Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 70. Rest of Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 71. Rest of Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 72. Rest of Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 73. Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 74. Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 75. Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 76. Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 77. UAE PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 78. UAE PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 79. UAE PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 80. UAE PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 81. Saudi Arabia PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 82. Saudi Arabia PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 83. Saudi Arabia PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 84. Saudi Arabia PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 85. South Africa PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 86. South Africa PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 87. South Africa PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 88. South Africa PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 89. Rest of Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 90. Rest of Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 91. Rest of Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 92. Rest of Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 93. South and Central America PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 94. South and Central America PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 95. South and Central America PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 96. South and Central America PACS and RIS Market Revenue and Forecasts to 2027, By End user (US$ Mn)

Table 97. Argentina PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 98. Argentina PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 99. Argentina PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 100. Argentina PACS and RIS Market Revenue and Forecasts to 2027, By End user (US$ Mn)

Table 101. Brazil PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 102. Brazil PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 103. Brazil PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 104. Brazil PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 105. Rest of South and Central America PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)

Table 106. Rest of South and Central America PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)

Table 107. Rest of South and Central America PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)

Table 108. Rest of South and Central America PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 109. Recent Collaborations by Players in The PACS and RIS Market

Table 110. Recent Agreements, Partnerships and Joint Ventures by Players in The PACS and RIS Market

Table 111. Recent Acquisitions by Players in The PACS and RIS Market

Table 112. Recent Product Launches in the PACS and RIS Market

Table 113. Recent Product Approval & Other Organic Growth Strategies in the PACS and RIS Market

Table 114. Glossary of Terms, PACS and RIS Market

LIST OF FIGURES

Figure 1. PACS and RIS Market Segmentation

Figure 2. PACS and RIS Segmentation, by Region

Figure 3. PACS and RIS Market Overview

Figure 4. Picture Archive and Communication System (PACS) Held Largest Share of PACS and RIS Market in 2019

Figure 5. PACS and RIS Market in Asia Pacific Region to Show Remarkable Growth During Forecast Period

Figure 6. Global PACS and RIS Market, By Geography (US$ Million)

Figure 7. Global PACS and RIS Market- Leading Country Markets (US$ Million)

Figure 8. Global PACS and RIS Market, Industry Landscape

Figure 9. North America : PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia - Pacific: PEST Analysis

Figure 12. Middle East & Africa: PEST Analysis

Figure 13. South & Central America: PEST Analysis

Figure 14. PACS and RIS Market Impact Analysis of Driver and Restraints

Figure 15. Global PACS and RIS Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 16. Global PACS and RIS Market – by Geography Forecasts and Analysis – 2019- 2027

Figure 17. Prominent Players in the PACS and RIS Market

Figure 18. Global PACS and RIS Market, by Product, 2019 & 2027 (% Share)

Figure 19. Global Picture Archive and Communication System (PACS) Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20. Global Orthopedic PACS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21. Global Oncology PACS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22. Global Cardiology PACS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23. Global Dental PACS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24. Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25. Global Radiology Information System (RIS) Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26. Global PACS and RIS Market, by Component, 2019 & 2027 ((% Share)

Figure 27. Global Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 28. Global Hardware Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29. Global Services Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 30. Global PACS and RIS Market, By Deployment, 2019 & 2027 (% Share)

Figure 31. Global Web-Based Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 32. Global On-Premise Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 33. Global Cloud-Based Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 34. Global PACS and RIS Market, By End User, 2019 & 2027 (% Share)

Figure 35. Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 36. Global Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 37. Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 38. North America PACS and RIS Market Revenue Overview, by Country, 2018 (US$ Mn)

Figure 39. North America PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 40. North America PACS and RIS Market Revenue and Forecasts to 2027, By Country (%)

Figure 41. US PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 42. Canada PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 43. Mexico PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 44. Europe PACS and RIS Market Revenue Overview, by Country, 2019 (US$ MN)

Figure 45. Europe PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 46. Europe PACS and RIS Market Revenue and Forecasts to 2027, By Country (%)

Figure 47. UK PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 48. Germany PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 49. France PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 50. Italy PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 51. Spain PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 52. Rest of Europe PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 53. Asia Pacific PACS and RIS Market Revenue Overview, by Country, 2019 (US$ MN)

Figure 54. Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 55. Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027, By Country (%)

Figure 56. Japan PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 57. China PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 58. India PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 59. South Korea PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 60. Australia PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 61. Rest of Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 62. Middle East & Africa PACS and RIS Market Revenue Overview, by Country, 2019 (US$ MN)

Figure 63. Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 64. Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027, By Country (%)

Figure 65. UAE PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 66. Saudi Arabia PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 67. South Africa PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 68. Rest of Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 69. South and Central America PACS and RIS Market Revenue Overview, by Country, 2019 (US$ MN)

Figure 70. South and Central America PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 71. South and Central America PACS and RIS Market Revenue and Forecasts to 2027, By Country (%)

Figure 72. Argentina PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 73. Brazil PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 74. Rest of South and Central America PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 75. Impact of COVID-19 Pandemic on PACS and RIS market in North American Countries

Figure 76. Impact of COVID-19 Pandemic on PACS and RISs market in European Countries

Figure 77. Impact of COVID-19 Pandemic on PACS and RISs Market in Asia Pacific Countries

Figure 78. Impact Of COVID-19 Pandemic on PACS and RISs Market in Middle East and Africa Countries

Figure 79. Impact Of COVID-19 Pandemic on PACS and RIS Market in South and Central America Countries

Figure 80. Growth Strategies in the PACS and RIS Market, 2017-2020

Figure 81. Inorganic Developments in the PACS and RIS Market, 2017-2020 (%)

Figure 82. Organic Growth Strategies in the PACS and RIS Market, 2017-2020 (%)

The List of Companies - PACS and RIS Market

  1. Agfa-Gevaert Group
  2. INFINITT Healthcare Co., Ltd.
  3. McKesson Corporation
  4. Cerner Corporation
  5. General Electric Company
  6. Koninklijke Philips N.V.
  7. FUJIFILM Holdings Corporation
  8. Siemens AG
  9. IBM
  10. Novarad

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to PACS and RIS Market